Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
D efinition — A procedure designed to remove the tubes and ovaries prior to the development of malignancy in women at high risk for ovarian cancer (BRCA1/2 germ-line mutations).
Heterozygous germ-line mutations in BRCA1 or BRCA2 occur in approximately 1 in 400 women in the general population and 1 in 40 women of Ashkenazi Jewish descent.
Lifetime risk of a pelvic fimbrial ovarian cancer is estimated at 40% and 10% for BRCA1 and BRCA2 mutation carriers respectively, without surgical intervention.
The vast majority of carcinomas are variants of high-grade serous carcinoma including “SET” (solid, endometrioid-like and transitional) patterns.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here